Skip to content

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07456436
Enrollment
111
Registered
2026-03-06
Start date
2024-11-26
Completion date
2027-07-23
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

Brief summary

This study assesses patient awareness and understanding of cancer clinical trials.

Detailed description

PRIMARY OBJECTIVE: I. To develop a multi-level data-driven intervention to improve cancer patient engagement with cancer clinical trials. OUTLINE: This is an observational study. Patients review educational materials and complete surveys on study.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Sponsors

University of Southern California
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH
Merck Sharp & Dohme LLC
CollaboratorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Eligible patient participants will be: * Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported * Have been diagnosed any cancer type

Exclusion criteria

* Participants (patients) will be excluded if they: * Are unable to give informed consent * Are unable to speak English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Change in Baseline Survey ScoreThrough study completion, up to 1 yearThe survey is a validated instrument (CHEKS\*) evaluated patients' knowledge and beliefs about cancer clinical trials (CCTs) before and after exposure to educational stimuli (written and video) detailing the purpose and characteristics of CCTs. The survey scores knowledge and beliefs about CCTs on a 100-point scale.The survey is collected before and after education materials are provided. The change in survey score will be analyzed. A paired t-test will be used to examine changes in CCT knowledge and Chi-Square tests of association to determine whether CCT knowledge and beliefs are associated with sociodemographic variables. \*Chung A, Donley T, Hays RD, et al. Development and evaluation of the Clinical Trial HEalth Knowledge and Beliefs Scale (CHEKS). Int J Environ Res Public Health. 2022;19(14):8660. doi:10.3390/ijerph19148660

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORChanita Hughes-Halbert

University of Southern California

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026